Se-Young Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Se-Young Park has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Na-Young Song
Department of Oral Biology, BK21 Four Project, Yonsei University College of Dentistry, Seoul, Republic of Korea
2 shared publications Bomi Kim
Department of Oral Biology, BK21 Four Project, Yonsei University College of Dentistry, Seoul, Republic of Korea
1 shared publication- Byeong-Oh Hwang
Department of Applied Life Science, The Graduate School, Yonsei University, Seoul 03722, Korea
1 shared publication Byung Kwan Choi
Department of Neurosurgery, Pusan National University College of Medicine, Yangsan, Republic of Korea
1 shared publication- Haeseung Lee
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, Republic of Korea
1 shared publication Jiwoo Kim
Department of Oral Biology, BK21 Four Project, Yonsei University College of Dentistry, Seoul, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 28 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10706
Cathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy; however, their use is frequently associated with immune-related adverse events (irAEs). In this study, anti-PD-L1 therapy exacerbates muscle wasting in tumor-bearing male mice despite its anti-tumor efficacy, accompanied by an accumulation of CD8+ T cells in muscle. Single-cell RNA sequencing identifies these cells as tissue-resident memory-like CD49a+ CD8+ T cells. While CD8+ T cell depletion prevents muscle wasting, it compromises the anti-tumor efficacy of anti-PD-L1. To resolve this paradox, we identify cathepsin L (CTSL) as a dual-target capable of suppressing both tumor progression and CD8+ T cell-mediated muscle wasting, through integrative transcriptomic analysis. Pharmacological inhibition of CTSL not only mitigates anti-PD-L1-induced muscle wasting but also further suppresses tumor growth, potentially via downregulation of BNIP3. Here, we show that CTSL is a dual-action target to uncouple anti-tumor efficacy from muscle-specific irAEs, offering a strategy to improve clinical outcomes of ICIs.
- 28 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10706
Open AccessCathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy; however, their use is frequently associated with immune-related adverse events (irAEs). In this study, anti-PD-L1 therapy exacerbates muscle wasting in tumor-bearing male mice despite its anti-tumor efficacy, accompanied by an accumulation of CD8+ T cells in muscle. Single-cell RNA sequencing identifies these cells as tissue-resident memory-like CD49a+ CD8+ T cells. While CD8+ T cell depletion prevents muscle wasting, it compromises the anti-tumor efficacy of anti-PD-L1. To resolve this paradox, we identify cathepsin L (CTSL) as a dual-target capable of suppressing both tumor progression and CD8+ T cell-mediated muscle wasting, through integrative transcriptomic analysis. Pharmacological inhibition of CTSL not only mitigates anti-PD-L1-induced muscle wasting but also further suppresses tumor growth, potentially via downregulation of BNIP3. Here, we show that CTSL is a dual-action target to uncouple anti-tumor efficacy from muscle-specific irAEs, offering a strategy to improve clinical outcomes of ICIs.
- Open Access
- 13 June 2023
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 56 (7) , 365-373
The role of myokines in cancer: crosstalk between skeletal muscle and tumor
Se-Young Park, Byeong-Oh Hwang & Na-Young Song. BMB Reports 2023;56:365-73. https://doi.org/10.5483/BMBRep.2023-0064
- 13 June 2023
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 56 (7) , 365-373
Open AccessThe role of myokines in cancer: crosstalk between skeletal muscle and tumor
Se-Young Park, Byeong-Oh Hwang & Na-Young Song. BMB Reports 2023;56:365-73. https://doi.org/10.5483/BMBRep.2023-0064